However, Ak7, an α2 function-blocking antibody, was only able to partially abrogate type I collagen-induced effects on colon cancer cell phenotype, suggesting the possible involvement of other collagen receptors. The gene discussed is ITGA2; the disease is malignant colon neoplasm.